HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ejersted, C. Articles by Oxlund, H. Search for Related Content PubMed Articles by Ejersted, C. Articles by Oxlund, H.

Human parathyroid hormone(1–34) increases bone formation and strength of cortical bone in aged rats

Ejersted C, Andreassen TT, Nilsson MHL, Oxlund H. Human parathyroid hormone(1–34) increases bone formation and strength of cortical bone in aged rats. Eur J Endocrinol 1994;130:201–7. ISSN 0804–4643

The effect of parathyroid hormone (PTH(1–34)) on mid-diaphyseal femoral cortical bone was studied in 2-year-old male rats. The rats were treated with daily injections of 1 5 nmol/kg PTH(1–34) or vehicle for 56 days, and labelled with tetracycline and calcein on day 15 and day 40, respectively. The PTH(1–34) treatment did not affect the body weights or the lengths of the femora. Fluorescence microscopy showed large intracortical cavities in the old vehicle-treated rats. After PTH treatment, double labelling and new bone formation filling in these cavities were found. Furthermore, an increased bone formation rate was observed both at the periosteum and at the endosteum. This resulted in an increase in the cross-sectional area and a decrease in the medullary area. Three-point bending analysis revealed an increase in ultimate load, ultimate stiffness, energy absorption and ultimate stress after the PTH(1–34) treatment. No differences were found between the groups regarding the hydroxyproline concentration or apparent and real densities. The ash concentration was, however, slightly reduced after PTH(1–34) treatment. The PTH(1–34) treatment of old rats induced the formation of bone both from the periosteum and endosteum, with a pronounced filling in of intracortical cavities, and, furthermore, a marked increase in the biomechanical competence of the cortical bone.

Charlotte Ejersted, Department of Connective Tissue Biology, Institute of Anatomy, University of Aarhus, DK-8000 Aarhus C. Denmark

This article has been cited by other articles:

				K. Kitahara, M. Ishijima, S. R. Rittling, K. Tsuji, H. Kurosawa, A. Nifuji, D. T. Denhardt, and M. Noda Osteopontin Deficiency Induces Parathyroid Hormone Enhancement of Cortical Bone Formation Endocrinology, May 1, 2003; 144(5): 2132 - 2140. [Abstract] [Full Text] [PDF]

				M. Sato, J. Vahle, A. Schmidt, M. Westmore, S. Smith, E. Rowley, and L. Y. Ma Abnormal Bone Architecture and Biomechanical Properties with Near-Lifetime Treatment of Rats with PTH Endocrinology, September 1, 2002; 143(9): 3230 - 3242. [Abstract] [Full Text] [PDF]

				M. Sato, Y. L. Ma, J. M. Hock, M. S. Westmore, J. Vahle, A. Villanueva, and C. H. Turner Skeletal Efficacy with Parathyroid Hormone in Rats Was Not Entirely Beneficial with Long-Term Treatment J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 304 - 313. [Abstract] [Full Text] [PDF]

				H. Oxlund, N. B. Andersen, G. Ortoft, H. Orskov, and T. T. Andreassen Growth Hormone and Mild Exercise in Combination Markedly Enhance Cortical Bone Formation and Strength in Old Rats Endocrinology, April 1, 1998; 139(4): 1899 - 1904. [Abstract] [Full Text] [PDF]

				C. Ohlsson, B.-A. Bengtsson, O. G. P. Isaksson, T. T. Andreassen, and M. C. Slootweg Growth Hormone and Bone Endocr. Rev., February 1, 1998; 19(1): 55 - 79. [Abstract] [Full Text]